로딩 중…
지수 로딩 중…
한국맥널티
222980· KOSDAQ· Consumer Staples· Food, Beverage & Tobacco
₩1,849-5.18%
2026-06-19
Price Chart
한국맥널티-52.04%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 20.40B KRW |
| Revenue | 95.26B KRW |
| Net Income | -184.1M KRW |
| Total Assets | 84.95B KRW |
| Net Assets | 37.59B KRW |
| Employees | 114 |
| Value | |
| P/B | 0.54x |
| P/S | 0.21x |
| FCF Yield | 24.52% |
| Profitability | |
| ROE | -0.49% |
| ROA | -0.22% |
| Op. Margin | -1.06% |
| Revenue Growth | -4.26% |
| Financial Health | |
| Debt Ratio | 225.98% |
| Total Debt | 35.23B KRW |
| FCF | 5.00B KRW |
| Cash | 2.04B KRW |
| Current Ratio | 1.15x |
| Dividend | |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -52.04% |
| 1M Return | -11.74% |
| From 52W High | -59.45% |
| 1Y MDD | -57.33% |
| Trading | |
| Volume | 9,891 shares |
| Foreign Own. | 2.08% |
| Per Share | |
| EPS | -37 KRW |
| BPS | 3,139 KRW |
Company Info
Korea McNulty, established in 1997 and headquartered in Cheonan, Chungcheongnam-do, primarily engages in coffee manufacturing and processing. In 2020, it spun off its pharmaceutical business, establishing McNulty Pharm Co., Ltd. and McNulty Bio Co., Ltd. as affiliates. The company's coffee division covers the entire process from green beans to roasted coffee products, while its pharmaceutical division produces general and specialized pharmaceuticals, alongside CMO and CSO services. Korea McNulty is expanding its business by entering large distribution channels, increasing B2B sales, launching a coffee academy, and pursuing the conversion of its Chinese sales subsidiary.